InvestorsHub Logo
Followers 840
Posts 120475
Boards Moderated 18
Alias Born 09/05/2002

Re: None

Monday, 05/20/2019 4:55:13 PM

Monday, May 20, 2019 4:55:13 PM

Post# of 875
Keytruda monotherapy fails to show OS benefit vs chemotherapy in second/third-line TNBC (KEYNOTE-119):

https://finance.yahoo.com/news/merck-provides-phase-3-keynote-203000074.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News